Galectin Therapeutics Inc. | ||||
NCM : GALT || Location: United States | ||||
$2.39-0.02 (-0.83%) |
0.06 M | 2.3 - 2.43 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 2.142 M |
Feb. 29, 2024 | 2.100 M |
Feb. 15, 2024 | 2.079 M |
Jan. 31, 2024 | 2.076 M |
Jan. 12, 2024 | 2.094 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
09/30/2023 | -0.16 | -0.24 | -47.06% |
06/30/2023 | -0.21 | -0.15 | 29.97% |
03/31/2023 | -0.21 | -0.19 | 11.30% |
12/31/2022 | -0.17 | -0.18 | -3.81% |
09/30/2022 | -0.20 | -0.14 | 30.00% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 61.849M | Shares Float | 42.638M |
Short Float | 2.142M | Market Cap | 147.82M |
Institution ownership | 11.69% | Insider ownership | 31.070% |
Earnings Date | 05/13/2024 BMO | Cash Per Share | ? |
Trailing EPS | -0.76 | Forward EPS | -0.66 |